ATE419276T2
Composition of antibodies with high ADCC
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 12 April 2021, 5.5 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
9 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9
89 members in 11 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 0004685 | France | A |
Members89
| Document | Office | Kind | |
|---|---|---|---|
| US934812A | United States of America | A | |
| US939085A | United States of America | A | |
| US960637A | United States of America | A | |
| CA2406033A1 | Canada | A1 | |
| WO0177181A2 | World Intellectual Property Organization (WIPO) | A2 | |
| FR2807767A1 | France | A1 | |
| AU2001254858B2 | Australia | B2 | |
| AU5485801A | Australia | A | |
| WO0177181A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1272527A2 | European Patent Office (EPO) | A2 | |
| US2003175969A1 | United States of America | A1 | |
| JP2003534781A | Japan | A | |
| FR2807767B1 | France | B1 | |
| EP1518864A2 | European Patent Office (EPO) | A2 | |
| US2005249722A1 | United States of America | A1 | |
| US2007009522A1 | United States of America | A1 | |
| AU2007202060A1 | Australia | A1 | |
| EP1272527B1 | European Patent Office (EPO) | B1 | |
| AT419276T | Austria | T | |
| ATE419276T2This record | Austria | T2 | |
| DE60137210D1 | Germany | D1 | |
| DK1272527T3 | Denmark | T3 | |
| ES2320412T3 | Spain | T3 | |
| US7541029B2 | United States of America | B2 | |
| EP1518864A3 | European Patent Office (EPO) | A3 | |
| US7579170B2 | United States of America | B2 | |
| AU2007202060B2 | Australia | B2 | |
| AU2010257417A1 | Australia | A1 | |
| US2011052571A1 | United States of America | A1 | |
| US2011059072A1 | United States of America | A1 | |
| US2011059073A1 | United States of America | A1 | |
| US7931895B2 | United States of America | B2 | |
| EP2341078A2 | European Patent Office (EPO) | A2 | |
| US2011223658A1 | United States of America | A1 | |
| EP2341078A3 | European Patent Office (EPO) | A3 | |
| US8124078B2 | United States of America | B2 | |
| AU2010257417B2 | Australia | B2 | |
| US8153124B2 | United States of America | B2 | |
| US8178093B2 | United States of America | B2 | |
| AU2012203957A1 | Australia | A1 | |
| JP2012191938A | Japan | A | |
| JP2012193184A | Japan | A | |
| JP2012193185A | Japan | A | |
| US2012258096A1 | United States of America | A1 | |
| US2012259095A1 | United States of America | A1 | |
| US8357370B2 | United States of America | B2 | |
| US8409572B2 | United States of America | B2 | |
| JP5192625B2 | Japan | B2 | |
| JP2013155198A | Japan | A | |
| US8685725B2 | United States of America | B2 | |
| AU2012203957B2 | Australia | B2 | |
| CA2406033C | Canada | C | |
| US2014162356A1 | United States of America | A1 | |
| AU2014208242A1 | Australia | A1 | |
| EP1518864B1 | European Patent Office (EPO) | B1 | |
| ES2525762T3 | Spain | T3 | |
| DK1518864T3 | Denmark | T3 | |
| JP5722278B2 | Japan | B2 | |
| JP5722279B2 | Japan | B2 | |
| US2015152189A1 | United States of America | A1 | |
| US2015266972A1 | United States of America | A1 | |
| JP5788432B2 | Japan | B2 | |
| EP2947099A1 | European Patent Office (EPO) | A1 | |
| JP2015211696A | Japan | A | |
| JP2015221827A | Japan | A | |
| JP5837859B2 | Japan | B2 | |
| AU2014208242B2 | Australia | B2 | |
| AU2016204535A1 | Australia | A1 | |
| EP2341078B1 | European Patent Office (EPO) | B1 | |
| AU2016204535B2 | Australia | B2 | |
| DK2341078T3 | Denmark | T3 | |
| JP2017012199A | Japan | A | |
| AU2017200299A1 | Australia | A1 | |
| ES2601241T3 | Spain | T3 | |
| AU2016204535C1 | Australia | C1 | |
| JP6124958B2 | Japan | B2 | |
| US9708409B2 | United States of America | B2 | |
| US9718889B2 | United States of America | B2 | |
| US9718890B2 | United States of America | B2 | |
| AU2017200299B2 | Australia | B2 | |
| JP2017214427A | Japan | A | |
| US2018002442A1 | United States of America | A1 | |
| EP1272527B2 | European Patent Office (EPO) | B2 | |
| US10081683B2 | United States of America | B2 | |
| DK1272527T4 | Denmark | T4 | |
| ES2320412T5 | Spain | T5 | |
| EP1518864B2 | European Patent Office (EPO) | B2 | |
| DK1518864T4 | Denmark | T4 | |
| ES2525762T5 | Spain | T5 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 1927974
Titles2
- German
- VERFAHREN VON ANTIKÖRPER MIT ADCC VIA CD16, Z.B. MONOKLONALE ANTIKÖRPER GEGEN RHESUS D
- English
- PROCESS OF ANTIBODIES WITH ADCC VIA CD16, E.G. MONOCLONAL ANTIBODIES AGAINST RHESUS D
Classification
- CPC, 18
- C07K16/34
- A61K2039/505
- C07K2317/14
- C07K2317/21
- C07K2317/41
- C07K2317/52
- C07K2317/732
- A61P15/00
- A61P17/00
- A61P31/00
- A61P31/04
- A61P31/12
- A61P35/00
- A61P37/02
- A61P37/04
- A61P37/06
- A61P7/00
- A61P7/04
- IPC, 14
- C12N15 09
- A61K39 395
- A61P7 00
- A61P15 00
- A61P31 00
- A61P35 00
- A61P37 02
- A61P37 06
- C07K16 34
- C12N5 10
- C12N5 20
- C12N15 02
- C12N15 13
- C12P21 08